Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Teresa Hatziioannou"'
Autor:
Matthias Preusser, Anna Sophie Berghoff, Thorsten Fuereder, Leonhard Müllauer, Gerwin Heller, Angelika Martina Starzer, Katharina Feldmann, Erwin Tomasich, Teresa Hatziioannou, Stefan Traint, Thomas Melchardt, Christoph Minichsdorfer, Ursula Schwarz-Nemec, Maja Nackenhorst
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 3 (2022)
Background Biomarkers for response prediction to anti-programmed cell death 1 (PD-1) immune checkpoint inhibitors (ICI) in patients with head and neck squamous cell carcinoma (HNSCC) are urgently needed for a personalized therapy approach. We investi
Externí odkaz:
https://doaj.org/article/e6550fd49f974f6795b61c4497460f1c
Autor:
Matthias Preusser, Leonhard Müllauer, Anna S Berghoff, Sebastian Bauer, Gerwin Heller, Thomas Brodowicz, Wolfgang Lamm, Katharina Feldmann, Angelika M Starzer, Rainer Hamacher, Erwin Tomasich, Teresa Hatziioannou, Stefan Traint, Iris M Noebauer-Huhmann, Julia Furtner, Gabriele Amann, Hans-Ulrich Schildhaus
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Some sarcomas respond to immune checkpoint inhibition, but predictive biomarkers are unknown. We analyzed tumor DNA methylation profiles in relation to immunological parameters and response to anti-programmed cell death 1 (anti-PD-1) immun
Externí odkaz:
https://doaj.org/article/a79916ad1b1542e9b504874a3913dd32
Autor:
Erwin Tomasich, Ariane Steindl, Christina Paiato, Teresa Hatziioannou, Markus Kleinberger, Luzia Berchtold, Rainer Puhr, Johannes A. Hainfellner, Leonhard Müllauer, Georg Widhalm, Franziska Eckert, Rupert Bartsch, Gerwin Heller, Matthias Preusser, Anna Sophie Berghoff
Publikováno v:
Clinical Cancer Research. :OF1-OF12
Purpose: HER3 belongs to a family of receptor tyrosine kinases with oncogenic properties and is targeted by a variety of novel anticancer agents. There is a huge unmet medical need for systemic treatment options in patients with brain metastases (BM)
Autor:
Maximilian J. Mair, Annette Leibetseder, Gerwin Heller, Rainer Puhr, Erwin Tomasich, Sebastian Goldberger, Teresa Hatziioannou, Adelheid Wöhrer, Georg Widhalm, Karin Dieckmann, Martin Aichholzer, Serge Weis, Tim von Oertzen, Julia Furtner, Josef Pichler, Matthias Preusser, Anna S. Berghoff
Publikováno v:
Clinical Cancer Research. 28:4565-4573
Purpose: The treatment of oligodendroglioma consists of tumor resection and radiochemotherapy. The timing of radiochemotherapy remains unclear, and predictive biomarkers are limited. Experimental Design: Adult patients diagnosed with isocitrate dehyd
Autor:
Anna Sophie Berghoff, Matthias Preusser, Gerwin Heller, Rupert Bartsch, Franziska Eckert, Georg Widhalm, Leonhard Müllauer, Johannes A. Hainfellner, Rainer Puhr, Luzia Berchtold, Markus Kleinberger, Teresa Hatziioannou, Christina Paiato, Ariane Steindl, Erwin Tomasich
Immune cell infiltration in BM of the three subtypes of BCa: Luminal (A), HER2-positive (B) and Triple-negative breast cancer (TNBC) (C).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d4b3ebfd74e6a41730f451dd770ba0b
https://doi.org/10.1158/1078-0432.22700616.v1
https://doi.org/10.1158/1078-0432.22700616.v1
Autor:
Anna Sophie Berghoff, Matthias Preusser, Gerwin Heller, Rupert Bartsch, Franziska Eckert, Georg Widhalm, Leonhard Müllauer, Johannes A. Hainfellner, Rainer Puhr, Luzia Berchtold, Markus Kleinberger, Teresa Hatziioannou, Christina Paiato, Ariane Steindl, Erwin Tomasich
Differentially methylated CpG sites in HER3+ vs HER3- breast cancer samples (HER2+ cohort)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4371f6b2ffd5d707011ee710b1417489
https://doi.org/10.1158/1078-0432.22700604.v1
https://doi.org/10.1158/1078-0432.22700604.v1
Autor:
Anna Sophie Berghoff, Matthias Preusser, Gerwin Heller, Rupert Bartsch, Franziska Eckert, Georg Widhalm, Leonhard Müllauer, Johannes A. Hainfellner, Rainer Puhr, Luzia Berchtold, Markus Kleinberger, Teresa Hatziioannou, Christina Paiato, Ariane Steindl, Erwin Tomasich
Purpose:HER3 belongs to a family of receptor tyrosine kinases with oncogenic properties and is targeted by a variety of novel anticancer agents. There is a huge unmet medical need for systemic treatment options in patients with brain metastases (BM).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0499103e01ba1f31e80eebf44f28d116
https://doi.org/10.1158/1078-0432.c.6618078.v1
https://doi.org/10.1158/1078-0432.c.6618078.v1
Autor:
Anna S. Berghoff, Matthias Preusser, Josef Pichler, Julia Furtner, Tim von Oertzen, Serge Weis, Martin Aichholzer, Karin Dieckmann, Georg Widhalm, Adelheid Wöhrer, Teresa Hatziioannou, Sebastian Goldberger, Erwin Tomasich, Rainer Puhr, Gerwin Heller, Annette Leibetseder, Maximilian J. Mair
Purpose:The treatment of oligodendroglioma consists of tumor resection and radiochemotherapy. The timing of radiochemotherapy remains unclear, and predictive biomarkers are limited.Experimental Design:Adult patients diagnosed with isocitrate dehydrog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ff9a71f709a1ae3442292ad6c50c262
https://doi.org/10.1158/1078-0432.c.6532964
https://doi.org/10.1158/1078-0432.c.6532964
Autor:
Angelika Martina Starzer, Gerwin Heller, Erwin Tomasich, Thomas Melchardt, Katharina Feldmann, Teresa Hatziioannou, Stefan Traint, Christoph Minichsdorfer, Ursula Schwarz-Nemec, Maja Nackenhorst, Leonhard Müllauer, Matthias Preusser, Anna Sophie Berghoff, Thorsten Fuereder
Publikováno v:
Journal for immunotherapy of cancer. 10(3)
BackgroundBiomarkers for response prediction to anti-programmed cell death 1 (PD-1) immune checkpoint inhibitors (ICI) in patients with head and neck squamous cell carcinoma (HNSCC) are urgently needed for a personalized therapy approach. We investig
Autor:
Stefan Traint, Sebastian Bauer, Thomas Brodowicz, Gerwin Heller, Katharina Feldmann, Julia Furtner, Gabriele Amann, Rainer Hamacher, Teresa Hatziioannou, Iris M. Noebauer-Huhmann, Leonhard Müllauer, Wolfgang Lamm, Angelika M. Starzer, Erwin Tomasich, Hans-Ulrich Schildhaus, Anna S. Berghoff, Matthias Preusser
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundSome sarcomas respond to immune checkpoint inhibition, but predictive biomarkers are unknown. We analyzed tumor DNA methylation profiles in relation to immunological parameters and response to anti-programmed cell death 1 (anti-PD-1) immune